These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Nonalcoholic steatohepatitis versus steatosis: adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism. Musso G; Cassader M; De Michieli F; Rosina F; Orlandi F; Gambino R Hepatology; 2012 Sep; 56(3):933-42. PubMed ID: 22684858 [TBL] [Abstract][Full Text] [Related]
10. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients. González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671 [TBL] [Abstract][Full Text] [Related]
11. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis. Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473 [TBL] [Abstract][Full Text] [Related]
12. Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease. Croci I; Byrne NM; Choquette S; Hills AP; Chachay VS; Clouston AD; O'Moore-Sullivan TM; Macdonald GA; Prins JB; Hickman IJ Gut; 2013 Nov; 62(11):1625-33. PubMed ID: 23077135 [TBL] [Abstract][Full Text] [Related]
13. Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease. Targher G; Bertolini L; Rodella S; Zoppini G; Scala L; Zenari L; Falezza G Clin Endocrinol (Oxf); 2006 Jun; 64(6):679-83. PubMed ID: 16712671 [TBL] [Abstract][Full Text] [Related]
14. The association of the steatosis severity, NAFLD fibrosis score and FIB-4 index with atherogenic dyslipidaemia in adult patients with NAFLD: A cross-sectional study. Tutunchi H; Naeini F; Ebrahimi-Mameghani M; Mobasseri M; Naghshi S; Ostadrahimi A Int J Clin Pract; 2021 Jun; 75(6):e14131. PubMed ID: 33683797 [TBL] [Abstract][Full Text] [Related]
15. Polymorphism in microsomal triglyceride transfer protein: a link between liver disease and atherogenic postprandial lipid profile in NASH? Gambino R; Cassader M; Pagano G; Durazzo M; Musso G Hepatology; 2007 May; 45(5):1097-107. PubMed ID: 17464986 [TBL] [Abstract][Full Text] [Related]
16. The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. Ryan MC; Itsiopoulos C; Thodis T; Ward G; Trost N; Hofferberth S; O'Dea K; Desmond PV; Johnson NA; Wilson AM J Hepatol; 2013 Jul; 59(1):138-43. PubMed ID: 23485520 [TBL] [Abstract][Full Text] [Related]
17. The G-250A polymorphism in the hepatic lipase gene promoter is associated with changes in hepatic lipase activity and LDL cholesterol: The KANWU Study. Lindi V; Schwab U; Louheranta A; Vessby B; Hermansen K; Tapsell L; Riccardi G; Rivellese AA; Laakso M; Uusitupa MI; Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):88-95. PubMed ID: 17327141 [TBL] [Abstract][Full Text] [Related]
18. Relation of hepatic steatosis to atherogenic dyslipidemia. Makadia SS; Blaha M; Keenan T; Ndumele C; Jones S; DeFilippis A; Martin S; Kohli P; Conceicao R; Carvalho J; Nasir K; Blumenthal R; Santos RD Am J Cardiol; 2013 Nov; 112(10):1599-604. PubMed ID: 24012029 [TBL] [Abstract][Full Text] [Related]
19. Influence of hepatic steatosis (fatty liver) on severity and composition of dyslipidemia in type 2 diabetes. Toledo FG; Sniderman AD; Kelley DE Diabetes Care; 2006 Aug; 29(8):1845-50. PubMed ID: 16873790 [TBL] [Abstract][Full Text] [Related]